Roux-En-Y Gastric Bypass

Both Roux-en-Y gastric bypass and sleeve gastrectomy reduced health care expenditures after surgery for adults with type 2 diabetes and obesity, according to data published in Annals of Internal Medicine.

Incretin-based obesity medications are targeted at appetite signaling in a person’s brain, altering energy equilibrium and allowing greater weight loss than lifestyle intervention, according to a speaker.

PHILADELPHIA — Tirzepatide 15 mg produced similar weight loss results as bariatric surgery among patients with obesity but had a favorable safety profile, according to a presenter at the ACG Annual Scientific Meeting.

SAN ANTONIO — Half of adolescents had two or more micronutrient deficiencies 10 years after metabolic and bariatric surgery, with deficiencies more common after Roux-en-Y gastric bypass, according to a presentation at ObesityWeek.

Adults with obesity who underwent bariatric surgery were less likely to develop pancreatic cancer than those who with obesity who did not have bariatric surgery, researchers reported.

Prepregnancy bariatric surgery was linked to lower risks for gestational hypertension, large for gestational age infants and gestational diabetes but increased risks for preterm birth and small for gestational age infants, data show.

Patients with severe obesity undergoing Roux-en-Y gastric bypass for weight loss demonstrated greater reductions in blood lipids at 6 weeks vs. those on a very low-energy diet, according to study results in JAMA Surgery.

In a single-center cohort of patients with heart failure and obesity, weight-loss surgery led to improved clinical outcomes including reduced BMI and HbA1c and less reliance on diuretics, researchers reported.

Researchers reported low perioperative risk for complications among patients who underwent sleeve gastrectomy or Roux-en-Y gastric bypass, with no clinically significant difference between groups, according to a study in JAMA Network Open.

Nearly half of adolescent patients who underwent Roux-en-Y gastric bypass or vertical sleeve gastrectomy had increased alcohol use and were at risk for alcohol-related harm and problems within 8 years of surgery, according to study results.